United Therapeutics (UTHR) Tops Q2 EPS by 82c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $497.59 --0%
Revenue Growth %: -1.2%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -1.2%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $3.98, $0.82 better than the analyst estimate of $3.16. Revenue for the quarter came in at $444.5 million versus the consensus estimate of $368.58 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- Oppenheimer Starts Teva Pharma (TEVA) at Outperform
- Activist Jana Partners calls for Six Flags sale - WSJ
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
